Frontiers | Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study IntroductionThe coronavirus disease 2019 (COVID-19) pandemic threatened public health and placed a significant burden on medical resources. The Immunophenoty...

Our collaborators identify chief predictor of #covid19 severity + death. Many authors include members of #IMPACC network: @rrmsky.bsky.social @bjoernpeters.bsky.social @skleinstein.bsky.social @sesmalab.bsky.social
@joanndarce.bsky.social @droferlevy.bsky.social
www.frontiersin.org/journals/med...

JCI Insight - High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19

Our collaborators unpacked a CD16 #polymorphism linked to #severe #covid19
Authors include: @skleinstein.bsky.social @bjoernpeters.bsky.social @sesmalab.bsky.social
@vivianasimonlab.bsky.social
@joanndarce.bsky.social
IMPACC group
insight.jci.org/articles/vie...

Identification of a multi-omics factor predictive of long COVID in the IMPACC study Following SARS-CoV-2 infection, ∼10-35% of COVID-19 patients experience long COVID (LC), in which often debilitating symptoms persist for at least three months. Elucidating the biologic underpinnings ...

Our manuscript on multiomics prediction of #LongCOVID is now up on bioRxiv! 🎉 Huge kudos to the entire #IMPACC Network, especially Lauren Ehrlich (UTex), Gisela Gabernet (Yale), and our incredible multiomics team for pushing this forward. Now, we wait! 🚀📑 #SystemsBiology #COVID19